|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/14 | |
| C07D 403/04 | |||
| A61P 35/00 |
| (11) | Number of the document | 3423445 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17706783.2 |
| Date of filing the European patent application | 2017-02-23 | |
| (97) | Date of publication of the European application | 2019-01-09 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2017/054139 |
| Date | 2017-02-23 |
| (87) | Number | WO 2017/148787 |
| Date | 2017-09-08 |
| (30) | Number | Date | Country code |
| 201603745 | 2016-03-04 | GB |
| (72) |
MAMMOLITI, Oscar, BE
JANSEN, Koen, Karel, BE
PALISSE, Adeline, Marie, Elise, BE
JOANNESSE, Caroline, Martine, Andrée-Marie, BE
MENET, Christel, Jeanne, Marie, BE
ALLART, Brigitte, BE
EL BKASSINY, Sandy, BE
|
| (73) |
Galapagos NV,
Generaal De Wittelaan L11/A3, 2800 Mechelen,
BE
|
| (54) | NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS |
| NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS |